Willingness to Pay for Quality-Adjusted Life Years: Empirical Inconsistency Between Cost-Effectiveness Analysis and Economic Welfare Theory
نویسندگان
چکیده
We design and conduct a stated-preference survey to test whether willingness to pay (WTP) to reduce risk of acute illness is proportional to the corresponding change in expected qualityadjusted life years (QALYs). For the short-term illnesses we consider, proportionality is required by economic theory if QALYs measure utility for health. Proportionality implies a constant WTP per QALY and that WTP is proportional to changes in both health quality and duration of illness. WTP is elicited using double-bounded, dichotomous-choice questions in which respondents (randomly selected from the United States general adult population, n = 2,795) decide whether to purchase a more expensive food to reduce the risk of foodborne illness. Health risks vary by baseline probability of illness, reduction in probability, duration and severity of illness, and conditional probability of mortality. The expected gain in QALYs is calculated using respondent-assessed decrements in health-related quality of life if ill combined with the stated duration of illness and reduction in probability. We reject the hypothesis that WTP is proportional to changes in expected QALYs and find diminishing marginal WTP for severity and duration of illness prevented. Our results suggest that individuals do not have a constant rate of WTP for changes in QALYs, which implies that cost-effectiveness analysis using cost per expected QALY gained is not consistent with economic welfare theory.
منابع مشابه
Monetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study
The aim of this study was to estimate monetary value of a QALY among heart disease patients and to identify its determinants.A cross-sectional survey with face-to-face interview was conducted with 196 cardiovascular disease patients from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The Euro Qol -5d (EQ-5D) questionnaire, visua...
متن کاملMonetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study
The aim of this study was to estimate monetary value of a QALY among heart disease patients and to identify its determinants.A cross-sectional survey with face-to-face interview was conducted with 196 cardiovascular disease patients from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The Euro Qol -5d (EQ-5D) questionnaire, visua...
متن کاملIs it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
Cost-benefit analysis (CBA) is a recognised as the economic evaluation technique that accords most with the underlying principles of standard welfare economic theory. However, due to problems associated with the technique, economists evaluating resources allocation decisions in health care have most often used cost-effective analysis (CEA), in which health benefits are expressed in non-monetary...
متن کاملTeriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran
Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...
متن کاملTeriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran
Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...
متن کامل